Emerging complementary metal-oxide semiconductor (CMOS) technologies and their ongoing downscaling trend have opened an avenue to developing integrated systems for life sciences. They offer great advantages for the monolithic integration of several active elements, and the implementation of millions of biosensors along with their transducers and readout circuits on a single chip. Benefits include the ability to make highly dense systems with high...